In the last 5 decades, several studies have demonstrated that left ventricular (LV) hypertrophy (LVH), either determined by standard 12-lead electrocardiography or by echocardiography, is a powerful, independent predictor of nonfatal and fatal cardiovascular events or all-cause mortality in the general population 1-3 as well as in specific clinical settings, such as patients with systemic hypertension, 4-7 myocardial infarction, 8 angina pectoris, 9 congestive heart failure, 10 or chronic renal failure, 11 and elderly individuals. 12 Furthermore, regression or reduction of electrocardiographic and echocardiographic indexes of LVH has been repeatedly shown to predict a lower risk for subsequent cardiovascular disease and death. [13] [14] [15] Echocardiography is recognized to be more sensitive than electrocardiography in detecting LVH, and its value as a predictor of LVH-related cardiovascular outcomes has been extensively investigated. 16 In the majority of reports, LVH was diagnosed by calculating LV mass; this parameter has a greater agreement with necropsy-determined LV mass compared with echographic LV wall thickness (83.0% vs. 39.5%). 17 Yet, as recently documented by 2 multicentered, observational studies, a large fraction of echocardiographically based reports do not provide quantitative data on LV mass and LV geometry, this being the case also in hypertensive patients. Moreover, in several laboratories, LVH is only defined by linear measurements of LV wall thickness rather than by the more complex and time-consuming determination of LV mass. 18, 19 To the best of our knowledge, no population-based studies have compared the value of LV wall thickness and LV mass in predicting cardiovascular prognosis. This study was undertaken to address this issue by analyzing the data obtained in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study, a population-based, prospective, observational study performed in Italy. background Data on the prognostic value of echocardiographic left ventricular (LV) hypertrophy (LVH) as defined by LV wall thickness rather than LV mass estimate are scarce and not univocal. Thus, we investigated the value of LV mass index, wall thickness, and relative wall thickness (RWT) in predicting cardiovascular events in the PAMELA population.
In the last 5 decades, several studies have demonstrated that left ventricular (LV) hypertrophy (LVH), either determined by standard 12-lead electrocardiography or by echocardiography, is a powerful, independent predictor of nonfatal and fatal cardiovascular events or all-cause mortality in the general population [1] [2] [3] as well as in specific clinical settings, such as patients with systemic hypertension, 4-7 myocardial infarction, 8 angina pectoris, 9 congestive heart failure, 10 or chronic renal failure, 11 and elderly individuals. 12 Furthermore, regression or reduction of electrocardiographic and echocardiographic indexes of LVH has been repeatedly shown to predict a lower risk for subsequent cardiovascular disease and death. [13] [14] [15] Echocardiography is recognized to be more sensitive than electrocardiography in detecting LVH, and its value as a predictor of LVH-related cardiovascular outcomes has been extensively investigated. 16 In the majority of reports, LVH was diagnosed by calculating LV mass; this parameter has a greater agreement with necropsy-determined LV mass compared with echographic LV wall thickness (83.0% vs. 39.5%). 17 Yet, as recently documented by 2 multicentered, observational studies, a large fraction of echocardiographically based reports do not provide quantitative data on LV mass and LV geometry, this being the case also in hypertensive patients. Moreover, in several laboratories, LVH is only defined by linear measurements of LV wall thickness rather than by the more complex and time-consuming determination of LV mass. 18, 19 To the best of our knowledge, no population-based studies have compared the value of LV wall thickness and LV mass in predicting cardiovascular prognosis. This study was undertaken to address this issue by analyzing the data obtained in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study, a population-based, prospective, observational study performed in Italy.
Differential Value of Left Ventricular Mass Index and Wall
Thickness in Predicting Cardiovascular Prognosis: Data From the PAMELA Population Cesare Cuspidi, 1,2 Rita Facchetti, 1 Michele Bombelli, 1 Carla Sala, 3 Guido Grassi, 1, 4 and Giuseppe Mancia 1, 2 background Data on the prognostic value of echocardiographic left ventricular (LV) hypertrophy (LVH) as defined by LV wall thickness rather than LV mass estimate are scarce and not univocal. Thus, we investigated the value of LV mass index, wall thickness, and relative wall thickness (RWT) in predicting cardiovascular events in the PAMELA population.
methods
At entry 1,716 subjects underwent diagnostic tests, including laboratory investigations, 24-hour ambulatory blood pressure (BP) monitoring, and echocardiography. For the purpose of this analysis, all subjects were divided into quintiles of LV mass, LV mass/ body surface area (BSA), LV mass/height 2.7 , interventricular septum (IVS), posterior wall (PW) thickness, IVS+PW thickness, and RWT.
results
Over a follow-up of 148 months, 139 nonfatal or fatal cardiovascular events were documented. After adjustment for age, sex, BP, fasting blood glucose, total cholesterol, and use of antihypertensive drugs, only the subjects stratified in the highest quintiles of LV mass indexed to body surface area (BSA) or height 2.7 exhibited a greater likelihood of incident cardiovascular disease (relative risk (RR) = 2.72, 95% confidence interval (CI) = 1.05-7.00, P = 0.03; RR = 4.83, 95% CI = 1.45-16.13, P = 0.01, respectively) as compared with the first quintile (reference group). The same was not true for the highest quintiles of IVS, PW thickness, IVS+PW thickness, and RWT. Similar findings were found when echocardiographic parameters were expressed as continuous variables.
METHODS

Population
The PAMELA Study was carried out in a sample of 3,200 subjects representative of the population of Monza (a town near Milan, Italy) for sex and age decades (25-74 years). Participation rate was 64%, and thus data were collected from 2,051 subjects. The demographic characteristics of nonparticipants and participants were similar, and this was also the case for cardiovascular risk factors as assessed by data collected by phone interviews. Overall, 1,746 of 2,051 subjects had a valuable echocardiographic examination at baseline; of these, 30 subjects were excluded from the final analysis because we were unable to ascertain the outcome because they moved to other regions.
Entry data
The methods employed in the PAMELA Study have been described in detail previously. 20 Briefly, after an informed consent, subjects were invited to undergo a comprehensive clinical evaluation at the outpatient clinic of the S. Gerardo University Hospital of Monza in the morning of a working day. Collected data included a full medical history, blood and urine samples, physical examination, standard 12-lead electrocardiogram, echocardiogram, and 3 sphygmomanometric blood pressure (BP) measurements in the sitting position. Body weight was recorded to the nearest 0.1 kg using a calibrated electronic scale with the subjects wearing indoor clothing without shoes. Height was recorded to the nearest 0.5 cm using a standardized wall-mounted height board. Data collection included ambulatory BP, which was obtained by a monitoring device (Spacelabs 90207, Redmond, Washington, DC) set to obtain automated BP and heart rate oscillometric readings every 20 minutes over the 24 hours. During the monitoring period, the subjects were asked to pursue their normal activities and to self-measure BP at home twice, namely at 9:00 am and 9:00 pm using a semiautomatic oscillometric device (model HP 5331; Philips, Eindhoven, NT) on the arm contralateral to the one used for ambulatory BP monitoring.
Echocardiography
Echocardiography was performed according to standardized procedures, as previously reported. 21 In brief, M-mode and 2-dimensional echo examinations were carried out with a commercially available instrument (Acuson 128 CF; Computer Sonography, New York, NY). End-diastolic (d) and end-systolic (s) LV internal diameters (LVID), interventricular septum (IVS) thickness, and posterior wall (PW) thickness were measured offline from 2-dimensionally guided M-mode tracings recorded at a speed of 50-100 cm/s during at least 3 consecutive cycles according to the Penn convention. Relative wall thickness (RWT) was defined by the ratio of PW plus IVS thickness to LVIDd; LV mass was estimated by using the corrected American Society of Echocardiography (ASE) method: 0.8 × (1.04 × ((IVSd + LVIDd + PWTd) 3 -LVIDd)) 3 + 0.6 and normalized to body surface area or height 2.7 . 22 Echocardiographic tracings were obtained by 2 skilled operators and read by a third independent observer: the intraobserver coefficient of variation was 0.6% for LVIDd, 3.1% for IVSd thickness, and 3.2% for PWd thickness.
Follow-up
Participants were followed from the time of the initial medical visit (from 1990 to 1993) to 1 October 2004. Death certificates were coded using the International Classification of Diseases and Causes of Death, 10th revision (ICD-10). 23 The ICD-10 codes from I-0 to I-99 were considered as cardiovascular deaths; also nonfatal cardiovascular events were identified by hospital diagnosis using ICD-10 codes accessible online across all hospitals operating in Lombardy. They were validated by examining the clinical records available in each hospital according to MONICA criteria for coronary events and stroke (http:/www.thl/publications/monica/maual/index. htm) and according to Framingham criteria for heart failure. No blindness procedures were used to this purpose. 
Data analysis
In each subject, the 3 office BP measurements and the 2 home BP measurements obtained at the initial visit were separately averaged. Ambulatory BP readings were also averaged after editing for artifacts, based on preselected criteria. 24 The average of 3 measurements was used to define echocardiographic parameters.
Participants were divided into quintiles of LV parameters (i.e., LV mass, LV mass indexed to body surface area (BSA) or height 2.7 , IVS, PW thickness, IVS+PW thickness and RWT). This avoided the arbitrarily classification of LV structure as normal or abnormal, a difficult classification because at variance from LV mass index thickness normality values, as identified from their association with cardiovascular outcomes, were not available. Values were expressed as means ± SDs or percentages. Means were compared by the Student t test for independent samples, and categorical data were analyzed by the χ 2 test or Fisher exact test when appropriate. The hazard ratio (HR) of cardiovascular events (fatal and nonfatal) was calculated by the Cox proportional hazard model 25 considering the first quintile as reference. Data were adjusted for age, sex, office systolic BP, fasting blood glucose, total cholesterol, and use of antihypertensive drugs. Receiver operating characteristic curve analyses were performed to evaluate the diagnostic performance of echocardiographic parameters in predicting cardiovascular prognosis. All tests were 2-sided, and P < 0.05 was considered statistically significant. Statistical analysis was performed by SAS System (version 9.12; SAS Institute, Cary, NC).
RESULTS
Of the 2,051 subjects who participated in the study, 1,716 (aged 50 ± 14 years; 50.6% men) had a reliable echocardiographic tracing at the baseline examination and were considered for analysis (Table 1) .
Cutoff limits for the highest quintile of LV mass, LV mass/ BSA, LV mass/height 2.7 , IVS thickness, PW thickness, IVS+PW thickness, and RWT were 186 g, 102 g/m 2 , 48 g/height 2.7 , 1.06 cm, 0.98 cm, 2.03 cm, and 0.42, respectively. Note that the upper limits recommended by ASE/ European Association Echicardiography (EAE) guidelines for defining LVH and LV geometry are 1.0 cm for IVS and PW thickness and >0.42 for RWT. 26 Table 2 shows demographic, clinical, and echocardiographic characteristics of patients divided according to quintiles of LV mass indexed to BSA. From the lowest to the highest LV mass quintile, there was a progressive increase in mean age, male prevalence, office and out-of-office systolic and diastolic BP values, fasting blood glucose, total cholesterol, triglycerides, LV wall thicknesses, RWT, prevalence hypertension, and use of antihypertensive drugs. The opposite trend was observed for high-density lipoprotein cholesterol, and similar differences in demographic, clinical, and echocardiographic variables were observed across the quintiles of LV mass indexed to height 2.7 , IVS thickness (Table 3) , RWT (Table 4) , PWT, and IVS+PWT (data not shown).
Prognostic significance of baseline echocardiographic indexes
Over a follow-up of 148 months, a total of 179 nonfatal or fatal cardiovascular events were documented (67 coronary events, 65 strokes, 35 heart failures, and 12 deaths for other cardiovascular causes). Of these, 139 (78%) occurred in patients with reliable echocardiographic and BP data (47 strokes, 57 coronary events, 23 heart failures, and 12 cardiovascular events of other nature). Out of 139 events, 59 (42.5%) were fatal.
The majority of cardiovascular events occurred in the 2 highest quintiles of all echocardiographic indexes of LVH according to the following figures: LV mass = 64%, LV mass/ BSA = 70%, LV mass/height 2.7 = 66%, IVS thickness = 57%, PW thickness = 59%, IVS+PW thickness = 68%, and RWT = 53%, respectively.
In unadjusted models, the risk of cardiovascular morbidity and mortality progressively increased across the quintiles of all echocardiographic parameters included in the analysis. After adjustment for confounders (see Methods) only the highest quintiles of LV mass indexed to BSA or height 2.7 were independently associated with an increased risk of cardiovascular events. The same was not true for the highest quintiles of absolute LV mass, IVS or PW thickness, the sum of IVS and PW thickness, and RWT, for which no quintile showed the ability to independently predict cardiovascular outcomes. As shown in Table 5 , compared with the lowest quintile, the fully adjusted risk of cardiovascular events associated with the highest quintile was 2.72 (95% confidence interval (CI) = 1.05-7.00; P = 0.03) and 4.83 (95% CI = 1.45-16.13; P = 0.01) for LV mass/BSA and LV mass/height 2.7 , respectively, a nonsignificant difference being observed for all other measurements. Similar results were observed when data were further adjusted for ambulatory and home BP values (data not shown).
The value of echocardiographic parameters in predicting incident cardiovascular events was also investigated with 2 further approaches: (i) by performing receiver operating characteristic curves and (ii) by using echocardiographic variables as continuous measures instead of categorical ones. Receiver operating characteristic curves analysis showed that LV mass/BSA (area under the curve = 0.72) and LV mass/height 2.7 (area under the curve = 0.72) provided the best correlation with cardiovascular events. Table 6 summarizes relative hazard ratios for the risk of cardiovascular events associated with a unit increase in echocardiographic measures in unadjusted and adjusted models. Again, LV mass, LV mass/BSA, and LV mass/height 2.7 , but not linear LV measurements, were independently correlated with cardiovascular outcome.
Finally, we tested the value of echocardiographic variable in predicting all-cause death, although this was not the primary aim of our investigation. We found that LV mass, LV mass/BSA, and LV mass/height 2.7 persisted to be independently correlated with all-cause death after adjustment for several covariables (P < 0.0001). This was not true for PWT or RWT, whereas a marginal statistical significance was observed for IVS (P = 0.02).
DISCUSSIOn
The main finding of this study is that, at variance from LV mass index, echocardiographic estimates of LV thicknesses and RWT do not reliably stratify the risk of incident nonfatal and fatal cardiovascular events after adjusting for several covariables, including age, sex, BP, fasting blood glucose, and use of antihypertensive drugs. Several aspects of our results deserve to be commented on in relation to prior reports of the literature in this field.
Available evidence on the prognostic value of echocardiographic LVH based on measurement of LV wall thickness rather than on estimates of LV mass is scarce and not univocal. In a small group of nondiabetic patients with end-stage renal disease and severe LVH (i.e., IVS and or PW thickness ≥ 1.4 cm in diastole), Parfrey et al. 27 reported a 50% and 47% incidence of hospitalization for congestive heart failure and total mortality, respectively, during a follow-up period of 3-5 years. The corresponding figures in patients with normal LV structure or mild LVH were 16% and 10%, respectively. More recently, an observational study by Barbieri et al. that included 2,445 adults referred to a single-center echocardiographic laboratory for unselected indications showed that LVH, as defined by sex-specific cutoffs of IVS thickness recommended by the ASE/EAE guidelines, was unrelated to allcause death during a mean follow-up period of 2.5 years. 28 In contrast, LV mass/BSA values retained a significant, graded association with total mortality after adjustment for age, sex, LV ejection fraction, presence of moderate valve disease, and atrial fibrillation. In keeping with the results by Barbieri et al., 28 our study extends to a general population the notion Data are shown as means ± SD unless otherwise noted. P values are based on either analysis of variance (for continuous measures) or χ 2 test (for categorical variables).
Abbreviations: DBP, diastolic blood pressure; HDL, high-density lipoprotein; IVST, interventricular septum thickness; LVM, left ventricular mass; LVMI, left ventricular mass index; PWT, posterior wall thickness; RWT, relative wall thickness; SBP, systolic blood pressure.
that LVH as defined by linear dimensions of LV wall thickness has no independent value in predicting cardiovascular outcomes. At variance from the above-mentioned study investigating the predictive value of single linear LV parameter (IVS), 28 our analysis included also PW thickness, the sum of IVS plus PW thickness, and RWT. The lack of a significant relationship between these linear LV measurements and cardiovascular prognosis in our study may have multiple explanations. LV wall thickness is an unreliable surrogate of LV mass, despite the significant correlation between the 2 parameters. Since the seminal paper by Devereux et al., 17 a large number of reports have documented a limited agreement between LV mass index and wall thickness, as wide variations of the former parameter may occur among subjects with a narrow range of LV wall thickness. In the Framingham study, a substantial overlap of the value of IVS thickness was present between the groups with and without LVH as defined by LV mass index. 29 Leibowitz et al. , by comparing LVH prevalence as defined either by wall thickness or LV mass index based on a sex-specific criterion in 92 hypertensive individuals, showed that the former approach tended to over-and underestimate LVH in men and women, respectively, with a global accuracy of 70% compared with LV mass index. 30 Lastly, in the cohort examined by Barbieri et al., the agreement by the 2 methods in the classification of LVH severity was met by 1,340 of 2,445 subjects (52.6%; kappa = 0.29; 95% CI = 0.26-0.32). 28 Body size is a major determinant of LV mass; in clinical practice and the research setting echocardiographic parameters are currently normalized to this variable to discriminate the physiological increments of cardiac weight from the adaptive responses to pathological stimuli. To this purpose, LV mass is usually divided by BSA or height elevated to some power, usually height 2.7 or height 1.7 ,as suggested by recent investigations. 31 The linear measurements of LV such as wall thickness are not usually indexed to body size; the absolute LV wall thickness, however, is clearly influenced by body habitus, and this may limit the clinical and prognostic significance of this index of LVH, as shown in our series.
A further remarkable result of our study is that an independent correlation between RWT and incidence of cardiovascular disease was not found in our population. A consistent body of evidence supports the view that LV geometry, as assessed by RWT (being 0.42 the recommended partition value between normal from concentric LV geometry), in combination with LV mass level, may refine cardiovascular risk stratification, concentric LVH representing the geometric pattern at highest risk. 32 In contrast with findings mostly obtained in hypertensive cohorts and in high-risk populations, we failed to observe a significant association between RWT and cardiovascular outcomes; these data suggest that in the general population LV mass index is a better predictor of cardiovascular events than concentric or eccentric patterns of LV geometry. Of note, similar results were found by Eguchi et al. in a cohort of 379 hypertensive patients followed for 63 ± 26 months: patients in the highest quartile of LV mass index had a greater incidence of cardiovascular events in comparison with patients in the lowest quartile; this was not the case for RWT quartiles. 33 Further points deserve some mention. The optimal method for LV mass indexation in adults is still debated: indexation to height 2.7 has been reported to improve LVH detection in overweight/obese subjects, whereas classical indexation to BSA appears more suitable for normal-weight individuals. 31, 34 Moreover, the use LV mass/height 2.7 has been shown to preserve similar hazard ratios for cardiovascular events as LVH identified by LV mass/BSA. 35 This kind of evidence, however, is not univocal. In a previous study by our group, the increased risk associated with LVH in the PAMELA population was less consistent when LV mass was indexed for height 2.7 rather than for BSA. 3 Because LVH was more frequent when LV mass was assessed by height 2.7 than by BSA (328 vs. 230 subjects), this could be originated from the fact that specificity of height 2.7 -based quantification is limited. Our analysis does not confirm this previous finding because the strength of relation between cardiovascular events and LV mass indexed either to height 2.7 or BSA was similar. This apparent inconsistency may be related to the fact that in this study the subjects were not divided into 2 groups according to the presence/absence of LVH but in quintiles of LV mass index, with the subjects with high-normal values of LV mass being at higher risk than their counterparts with lower levels of LV mass index. This approach is more in keeping with the notion that the relationship between LV mass index and cardiovascular risk is continuous, 36 as further confirmed by our results showing an independent association between LV mass expressed as a continuous variable and incident cardiovascular disease (Table 5) . In additional analyses, we tested the predictive value of different echocardiographic diagnostic criteria, including those recommended by European Society Hypertension/European Society Cardiology (ESH/ ESC) guidelines 32 and those based on reference values from the PAMELA population. 21 LVH defined by both criteria was a strong, independent predictor of cardiovascular events (data not shown).
Some limitations of our study need to be acknowledged. First, we did not assess the prognostic impact of clear-cut increases of LV wall thickness (i.e., moderate or severe LV wall thickening); it should be noted, however, that the subjects stratified in the highest quintiles of IVS or PW thickness fulfilled the criteria for a mildly abnormal increase in such parameters according to ASE/EAE guidelines. 26 Second, we examined the prognostic significance of LVH indexes only at baseline and were not able to evaluate the impact of their serial changes because the echocardiographic variables were not available throughout the observation period. Third, we were unable to provide any information on the prognostic value of echocardiographic variables separately for men and women because sex-based analyses failed to show significant findings, probably because of the limited size of samples. Fourth, because cardiovascular events were ascertained on the basis of hospital diagnosis, our analysis did not consider cardiovascular morbidity not requiring hospitalization. Lastly, our results were obtained in a low-risk white population, and the extent to which they can be extrapolated to population samples at higher risk of cardiovascular disease or to different ethnic groups remains undetermined.
In conclusion, this study offers a new piece of evidence that echocardiographic LVH only defined by the linear measurement of LV wall thickness rather than by LV mass indexed to body size is unreliable for stratifying the risk of cardiovascular disease related to LVH in a general population. From a clinical standpoint, it is important that echocardiographic laboratories provide a systematic estimate of LV mass indexed to body size, which is a strong independent predictor of cardiovascular events, even in low-risk populations.
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